Virtu Financial’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14K Buy
+26,676
New +$19.6K ﹤0.01% 1431
2024
Q4
Sell
-17,804
Closed -$20K 2062
2024
Q3
$20K Buy
17,804
+3,533
+25% +$7.96K ﹤0.01% 1129
2024
Q2
$30K Buy
+14,271
New +$27.7K ﹤0.01% 981
2023
Q1
Sell
-2,476
Closed -$12K 2104
2022
Q4
$12K Sell
2,476
-449
-15% -$2.72K ﹤0.01% 1358
2022
Q3
$16K Buy
+2,925
New +$18.9K ﹤0.01% 1450
2022
Q2
Sell
-7,585
Closed -$40K 2081
2022
Q1
$40K Buy
+7,585
New +$43.7K ﹤0.01% 1185
2021
Q1
Sell
-5,980
Closed -$114K 2026
2020
Q4
$114K Buy
5,980
+872
+17% +$14.4K 0.01% 1025
2020
Q3
$51K Buy
+5,108
New +$59.1K 0.01% 821
2018
Q4
Sell
-6,754
Closed -$135K 1990
2018
Q3
$135K Buy
+6,754
New +$147K 0.01% 1149

Other funds holding TRIB

Virtu Financial's TRIB Position: Q1 2026 in Review

Virtu Financial opened a new position in Trinity Biotech (TRIB) in Q1 2026: 26,676 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings. This is a return to the name: Virtu Financial previously reported a position in TRIB as recently as Q3 2024.

Virtu Financial first reported a position in TRIB in Q3 2018 and has held it in 9 quarters since. The position peaked at $135K in Q3 2018. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Virtu Financial held 26,676 shares of Trinity Biotech worth $14K as of Q1 2026.
  • Trinity Biotech was a new Virtu Financial position in Q1 2026.
  • Trinity Biotech made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1431 holding.
  • Virtu Financial first reported a position in Trinity Biotech in Q3 2018 and has held it in 9 quarters since.
  • Virtu Financial's Trinity Biotech position peaked at $135K in Q3 2018.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.